Pharmaceuticals
Turing Pharma halves Daraprim price hike from 5,000% to 2,500%
27 Nov 2015
The small biotech company is now cutting what it charged hospitals, by up to 50 per cent for Daraprim, its parasitic infection drug
FDA threatens Dr Reddy’s with US import ban
26 Nov 2015
Turing does volte face on cutting price of drug Daraprim
26 Nov 2015
After virtually promising to cut the price of Daraprim - which it hiked by 50 times after acquiring it in August - New York based start-up Turing Pharmaceuticals now says it will take other measures to make the drug affordable
Shire preparing to mount new bid for Baxalta
25 Nov 2015
British drugmaker Shire Plc is preparing to table a new takeover offer for Baxalta, almost four months after the US biotech firm rejected its unsolicited $30-billion bid
US politicians unite to flay Pfizer-Allergan deal
24 Nov 2015
Democratic presidential front-runner Hillary Clinton said the deal would “leave US taxpayers holding the bag”, while her Republican rival Donald Trump called it “disgusting”
Pfizer to take over Allergan in historic $150-bn deal
23 Nov 2015
The deal, the largest ever in the healthcare sector, will make Pfizer the world’s biggest drug maker, but the tax-cutting ‘inversion’ move is sure to draw political ire
